Which has grown faster, NRC or NTLA?

Over the past five years, NTLA grew revenue faster — NRC at a -0.02% CAGR versus NTLA at 7.31%.

Does NRC or NTLA pay a bigger dividend?

NRC pays a dividend (2.81% yield), while NTLA has no payments in the available dividend history.

Is NRC or NTLA more profitable?

NRC runs the higher net margin — NRC at 4.18% versus NTLA at -672.16%.

How have NRC and NTLA total returns compared?

Over the past 10 years, NRC delivered 4.72% and NTLA delivered -3.34% annualized total return. Past performance doesn't predict future results.

NRC Health (NRC) vs Intellia Therapeutics, Inc. (NTLA)

A side-by-side comparison of NRC Health and Intellia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

NRC

NRC Health

$459M

$20.35HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

NTLA

Intellia Therapeutics, Inc.

$1.71B

$12.26HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — NRC vs NTLA

growth of $100 · dividends reinvested · last 10y

NRC +66.2% (+5.2%/yr)NTLA -28.8% (-3.3%/yr)NRC compounded faster over this window

NRC NTLA

NRC vs NTLA: by the numbers

•NTLA is the larger company ($1.71B vs $459M market cap).
•NRC is profitable (4.18% net margin) while NTLA runs a net loss (-672.16%).
•NTLA grew revenue faster over the past five years (7.31% vs -0.02% CAGR).
•NRC pays a dividend (2.81% yield), while NTLA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	NRC	NTLA
P/E ratio	80.63	N/A
Forward P/E	23.13	N/A
P/S ratio	3.28	28.79
P/B ratio	70.03	2.35
EV / EBITDA	23.34	N/A
FCF yield	4.72%	N/A

Profitability

Metric	NRC	NTLA
Gross margin	56.33%	76.47%
Operating margin	10.53%	-651.67%
Net margin	4.18%	-672.16%
ROE	89.43%	-54.96%
ROIC	8.75%	-54.45%

Dividends

Metric	NRC	NTLA
Dividend yield	2.81%	N/A
Payout ratio	237.72%	N/A

Growth (annualized)

Metric	NRC	NTLA
Revenue CAGR (5Y)	-0.02%	7.31%
EPS CAGR (5Y)	-18.88%	N/A
FCF CAGR (5Y)	-14.35%	N/A
Total return CAGR (5Y)	-10.90%	-38.17%

Frequently asked

Which has grown faster, NRC or NTLA?: Over the past five years, NTLA grew revenue faster — NRC at a -0.02% CAGR versus NTLA at 7.31%.
Does NRC or NTLA pay a bigger dividend?: NRC pays a dividend (2.81% yield), while NTLA has no payments in the available dividend history.
Is NRC or NTLA more profitable?: NRC runs the higher net margin — NRC at 4.18% versus NTLA at -672.16%.
How have NRC and NTLA total returns compared?: Over the past 10 years, NRC delivered 4.72% and NTLA delivered -3.34% annualized total return. Past performance doesn't predict future results.

Go deeper

Full NRC analysis Full NTLA analysis Interactive comparison tool

Dig into the metrics

NRC Health P/E ratio NRC Health dividend yield NRC Health ROE Intellia Therapeutics ROE NRC Health operating margin Intellia Therapeutics operating margin NRC Health revenue growth Intellia Therapeutics revenue growth NRC Health free cash flow Intellia Therapeutics free cash flow

NRC Health & Intellia Therapeutics appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.